IRS2-expressing cells retained their growth advantage when exposed to microglia CM (Supplementary Figure S4D and E) but not to lung CM (Supplementary Figure S5A and B) or in the in vivo subcutaneous tumor model (Figure 2F–K). Here, IRS2 is linked to neoplasm.